Johnson & Johnson has unveiled groundbreaking findings on nipocalimab, an investigational FcRn blocker, in a recent ...

The expression levels of immunoglobulin-related genes in these ... precisely locating the core regions and microenvironmental characteristics of aging sensitivity. The Immunoglobulin-associated ...